When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRSP - Vertex: The Cheapest And Highest Quality Monopoly In The Market
CRISPR Therapeutics AG
Currently trading at 5-year historical PEG and PE NTM of 0.7x and 19.9x, respectively, VRTX's monopoly in cystic fibrosis is being grossly underappreciated by sell-side analysts.
Long-term international expansion and pipeline opportunities represent a $4.8Bn and $9.5Bn TAM, respectively.
My target price of $316 represents a 41% upside. A true asymmetric return opportunity.